IP Library Granted Patent US 11,784,303
Granted Patent B2
US 11,784,303 · App. 16/893,564 · Granted Oct 10, 2023

Immobilized chalcogen and use thereof in a rechargeable battery

Inventors: Wen-Qing Xu (Sarver, PA); Elgin E. Eissler (Renfrew, PA); Xiaoming Li (Allison Park, PA); Chengkun Xu (Valencia, PA); Colin Moore (Butler, PA); Shailesh Patkar (Irwin, PA); Christopher S. Koeppen (New Hope, PA)
Assignee: II-VI DELAWARE, INC.
H01M4/1393H01M4/133H01M4/134H01M4/136H01M4/581H01M10/0525
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,784,303
App. No.
16/893,564
Granted
Oct 10, 2023
Kind
B2
Abstract

An immobilized chalcogen system or body includes a mixture or combination of chalcogen and carbon. The carbon can be in the form of a carbon skeleton. The chalcogen can include oxygen, sulfur, selenium, or tellurium, or a combination of any two or more of oxygen, sulfur, selenium, and tellurium. The activation energy for chalcogen to escape the immobilized chalcogen system or body is ≥96 kJ/mole.

Claims (32)

1. An immobilized chalcogen system or body comprising:

a mixture of chalcogen and a carbon, wherein an activation energy for a chalcogen particle to escape the immobilized chalcogen system or body ≥96 KJ/mole, and the carbon forms a carbon skeleton which includes a deactivation chemical functional group which withdraws electrons from a delocalized Extremely Massive Aromatic Conjugated (EMAC) π-bond system of the carbon skeleton.

2. The immobilized chalcogen system or body of claim 1 , wherein the chalcogen comprises one or more of the following: oxygen, sulfur, selenium, and/or tellurium.

3. The immobilized chalcogen system or body of claim 1 , wherein the immobilized chalcogen forms a coordination bond.

4. The immobilized chalcogen system or body of claim 1 , wherein the immobilized chalcogen forms an electron donor-acceptor bond.

5. The immobilized chalcogen system or body of claim 1 , wherein the carbon skeleton includes a carbo-cation center on the EMAC π-bond system.

6. The immobilized chalcogen system or body of claim 1 , wherein the deactivation chemical functional group includes an oxygen-containing group and the immobilized chalcogen system or body has group ≥0.1 millimole (mmol) O/g.

7. The immobilized chalcogen system or body of claim 6 , wherein the deactivation chemical functional group including the oxygen-containing group includes at least one of the following:

a formyl group, an aldehyde group, an acyl group, a ketone group, a carboxyl group, a carboxylic acid group, a carboxylate group, an ester group, an anhydride group, or a carbonyl group.

8. The immobilized chalcogen system or body of claim 1 , wherein the deactivation chemical functional group includes a nitrogen-containing group and the immobilized chalcogen system or body has ≥0.1 mmol N/g.

9. The immobilized chalcogen system or body of claim 8 , wherein the deactivation chemical functional group including the nitrogen-containing group includes at least one of the following:

a nitro (—NO 2 ) group;

a nitroso (—NO) group;

an ammonium (—N + R 3 ) group, where R is an alkyl group, an aryl group, or a H;

a cyano group (—CN);

a thiocyano group (—SCN); and/or

an isothiocyano group (—NCS).

10. The immobilized chalcogen system or body of claim 1 , wherein the deactivation chemical functional group includes a phosphorus-containing group and the immobilized chalcogen system or body has 0.1≥mmol P/g.

11. The immobilized chalcogen system or body of claim 10 , wherein the deactivation chemical functional group including the phosphorus-containing group includes at least one of the following:

a phosphonic acid group (—PO 3 H 2 ) or its salt (—PO 3 H − , —PO 3 2− );

a phosphonate (—PO 3 R 2 , —PO 3 HR, or —PO 3 R − );

a phosphonyl group (—POR 2 ), where R is an alkyl, aryl, any organic functional group; and/or

a phosphonium group (—P + R 3 ).

12. The immobilized chalcogen system or body of claim 1 , wherein the deactivation chemical functional group includes a halogen-containing group and the immobilized chalcogen system or body has ≥0.1 mmol X/g, wherein the halogen (X) comprises one of the following: fluorine, chlorine, bromine, and iodine.

13. The immobilized chalcogen system or body of claim 12 , wherein the deactivation chemical functional group including the halogen-containing group includes at least one of the following: F, Cl, Br, I, —CF 3 , —CCl 3 , —CBr 3 , —CI 3 , and/or a highly halogenated alkyl group with more than one carbon.

14. The immobilized chalcogen system or body of claim 1 , wherein the deactivation chemical functional group includes a sulfur-containing group and the immobilized chalcogen system or body has ≥0.1 mmol S/g.

15. The immobilized chalcogen system or body of claim 14 , wherein the deactivation chemical functional group including the sulfur-containing group includes at least one of the following:

a SO 3 H (a sulfonic acid) group;

a SCN (a thiocyano group);

a SO 2 R (a sulfonyl ester) group, where R is an alkyl group, aryl group or halogen;

a SO 2 CF 3 (a trifluoromethyl sulfonyl ester group); and/or

a SO 2 —O—R or a sulfonium group (—S + R 2 ), where each R is independently an alkyl group, aryl group or other organic functional group.

Assignments (2)
SECURITY INTEREST Recorded Jul 1, 2022
From: II-VI INCORPORATED; II-VI DELAWARE, INC.; M CUBED TECHNOLOGIES, INC.; II-VI PHOTONICS (US), INC.; PHOTOP TECHNOLOGIES, INC.; COHERENT, INC.
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 060562/0254 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 5, 2020
From: XU, WEN-QING; EISSLER, ELGIN E.; LI, XIAOMING; XU, CHENGKUN; MOORE, COLIN; PATKAR, SHAILESH; KOEPPEN, CHRISTOPHER S.
To: II-VI DELAWARE, INC.
Reel/Frame 052848/0470 →
Priority Claims (1)
CN 201510608018.4 · Sep 22, 2015 · national
Continuity (8)
Continuation PCTUS2020017516 · Feb 10, 2020
Continuation In Part 15434655 · Feb 16, 2017
Continuation In Part 15262407 · Sep 12, 2016
Provisional Application 62802929 · Feb 8, 2019
Provisional Application 62367314 · Jul 27, 2016
Provisional Application 62364113 · Jul 19, 2016
Provisional Application 62296286 · Feb 17, 2016
Related Publication 20200321608A1 · Oct 8, 2020